• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖/透明质酸纳米颗粒的不同制备方法:模板法与直接络合法。颗粒制备对形态、细胞摄取及沉默效率的影响。

The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency.

作者信息

Gennari Arianna, Rios de la Rosa Julio M, Hohn Erwin, Pelliccia Maria, Lallana Enrique, Donno Roberto, Tirella Annalisa, Tirelli Nicola

机构信息

Laboratory of Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163 Genova, Italy.

NorthWest Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom.

出版信息

Beilstein J Nanotechnol. 2019 Dec 30;10:2594-2608. doi: 10.3762/bjnano.10.250. eCollection 2019.

DOI:10.3762/bjnano.10.250
PMID:31976191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6964650/
Abstract

This study is about linking preparative processes of nanoparticles with the morphology of the nanoparticles and with their efficiency in delivering payloads intracellularly. The nanoparticles are composed of hyaluronic acid (HA) and chitosan; the former can address a nanoparticle to cell surface receptors such as CD44, the second allows both for entrapment of nucleic acids and for an endosomolytic activity that facilitates their liberation in the cytoplasm. Here, we have systematically compared nanoparticles prepared either A) through a two-step process based on intermediate (template) particles produced via ionotropic gelation of chitosan with triphosphate (TPP), which are then incubated with HA, or B) through direct polyelectrolyte complexation of chitosan and HA. Here we demonstrate that HA is capable to quantitatively replace TPP in the template process and significant aggregation takes place during the TPP-HA exchange. The templated chitosan/HA nanoparticles therefore have a mildly larger size (measured by dynamic light scattering alone or by field flow fractionation coupled to static or dynamic light scattering), and above all a higher aspect ratio ( / ) and a lower fractal dimension. We then compared the kinetics of uptake and the (antiluciferase) siRNA delivery performance in murine RAW 264.7 macrophages and in human HCT-116 colorectal tumor cells. The preparative method (and therefore the internal particle morphology) had little effect on the uptake kinetics and no statistically relevant influence on silencing (templated particles often showing a lower silencing). Cell-specific factors, on the contrary, overwhelmingly determined the efficacy of the carriers, with, e.g., those containing low-MW chitosan performing better in macrophages and those with high-MW chitosan in HCT-116.

摘要

本研究旨在将纳米颗粒的制备过程与纳米颗粒的形态及其在细胞内递送有效载荷的效率联系起来。这些纳米颗粒由透明质酸(HA)和壳聚糖组成;前者可使纳米颗粒靶向细胞表面受体,如CD44,后者既能包裹核酸,又具有溶酶体溶解活性,有助于核酸在细胞质中释放。在此,我们系统地比较了两种制备纳米颗粒的方法:A)两步法,基于壳聚糖与三磷酸(TPP)通过离子凝胶化产生的中间(模板)颗粒,然后与HA孵育;B)壳聚糖和HA直接进行聚电解质络合。我们在此证明,在模板法中HA能够定量替代TPP,并且在TPP - HA交换过程中会发生显著聚集。因此,模板化的壳聚糖/HA纳米颗粒尺寸略大(仅通过动态光散射或通过与静态或动态光散射耦合的场流分级法测量),最重要的是具有更高的纵横比(/)和更低的分形维数。然后,我们比较了在小鼠RAW 264.7巨噬细胞和人HCT - 116结肠直肠肿瘤细胞中的摄取动力学和(抗荧光素酶)siRNA递送性能。制备方法(以及因此内部颗粒形态)对摄取动力学影响很小,对沉默没有统计学上的显著影响(模板化颗粒通常显示较低的沉默效果)。相反,细胞特异性因素在很大程度上决定了载体的功效,例如,含有低分子量壳聚糖的载体在巨噬细胞中表现更好,而含有高分子量壳聚糖的载体在HCT - 116细胞中表现更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/fb5fb0547d31/Beilstein_J_Nanotechnol-10-2594-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/41fc4becf09f/Beilstein_J_Nanotechnol-10-2594-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/a7e29d5eb12d/Beilstein_J_Nanotechnol-10-2594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/51458a5d0e8c/Beilstein_J_Nanotechnol-10-2594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/81fd9e765eb9/Beilstein_J_Nanotechnol-10-2594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/fb81a4db23f5/Beilstein_J_Nanotechnol-10-2594-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/8d5ddd434b2c/Beilstein_J_Nanotechnol-10-2594-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/fb5fb0547d31/Beilstein_J_Nanotechnol-10-2594-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/41fc4becf09f/Beilstein_J_Nanotechnol-10-2594-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/a7e29d5eb12d/Beilstein_J_Nanotechnol-10-2594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/51458a5d0e8c/Beilstein_J_Nanotechnol-10-2594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/81fd9e765eb9/Beilstein_J_Nanotechnol-10-2594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/fb81a4db23f5/Beilstein_J_Nanotechnol-10-2594-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/8d5ddd434b2c/Beilstein_J_Nanotechnol-10-2594-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef9/6964650/fb5fb0547d31/Beilstein_J_Nanotechnol-10-2594-g007.jpg

相似文献

1
The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency.壳聚糖/透明质酸纳米颗粒的不同制备方法:模板法与直接络合法。颗粒制备对形态、细胞摄取及沉默效率的影响。
Beilstein J Nanotechnol. 2019 Dec 30;10:2594-2608. doi: 10.3762/bjnano.10.250. eCollection 2019.
2
Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.透明质酸包覆壳聚糖纳米粒:分子量依赖性对形态和透明质酸呈现的影响。
J Control Release. 2013 Dec 28;172(3):1142-50. doi: 10.1016/j.jconrel.2013.09.032. Epub 2013 Oct 6.
3
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.包裹基于壳聚糖纳米颗粒的聚乳酸-羟基乙酸共聚物微粒用于雷珠单抗的眼部递送
Mol Pharm. 2016 Sep 6;13(9):2923-40. doi: 10.1021/acs.molpharmaceut.6b00335. Epub 2016 Jun 22.
4
Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.壳聚糖/透明质酸纳米颗粒:用于RNA递送的理性设计再探讨
Mol Pharm. 2017 Jul 3;14(7):2422-2436. doi: 10.1021/acs.molpharmaceut.7b00320. Epub 2017 Jun 19.
5
HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery.HA 修饰壳聚糖纳米粒用于 CD44 介导的核酸递释
Macromol Biosci. 2013 Dec;13(12):1671-80. doi: 10.1002/mabi.201300302. Epub 2013 Sep 17.
6
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles.透明质酸(HA)作为一种工具,可调节和控制经 HA 涂层的纳米颗粒的受体介导摄取。
Biomaterials. 2013 Jul;34(21):5369-80. doi: 10.1016/j.biomaterials.2013.03.065. Epub 2013 Apr 21.
7
Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.甘露糖化使得透明质酸纳米颗粒能够协同(CD44/C 型凝集素)被树突状细胞摄取,但仅在正确呈现配体的情况下才会发生。
Adv Healthc Mater. 2016 Apr 20;5(8):966-76. doi: 10.1002/adhm.201500941. Epub 2016 Feb 10.
8
Development and characterisation of chitosan nanoparticles for siRNA delivery.用于小干扰RNA递送的壳聚糖纳米颗粒的研发与表征
J Control Release. 2006 Oct 10;115(2):216-25. doi: 10.1016/j.jconrel.2006.07.021. Epub 2006 Jul 25.
9
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.采用 CD44 靶向壳聚糖纳米粒将 PLXDC1 小干扰 RNA 选择性递送至内皮细胞用于上皮性卵巢癌的抗血管生成肿瘤治疗。
Drug Deliv. 2018 Nov;25(1):1394-1402. doi: 10.1080/10717544.2018.1480672.
10
Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.壳聚糖-透明质酸纳米粒用于基因沉默:透明质酸对纳米粒形成和活性的作用。
Colloids Surf B Biointerfaces. 2013 Mar 1;103:615-23. doi: 10.1016/j.colsurfb.2012.11.009. Epub 2012 Nov 23.

引用本文的文献

1
Production and Characterization of Nanoparticulate Polyelectrolyte Complexes of Chitosan-Catechol, Ulvan, and Hyaluronic Acid.壳聚糖-儿茶酚、岩藻依聚糖和透明质酸纳米级聚电解质复合物的制备与表征
ACS Omega. 2025 Jan 17;10(4):3474-3485. doi: 10.1021/acsomega.4c07429. eCollection 2025 Feb 4.
2
Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles.靶向胰腺癌中的缺氧诱导因子-1α:使用展示透明质酸的纳米颗粒递送小干扰RNA
Pharmaceutics. 2024 Sep 30;16(10):1286. doi: 10.3390/pharmaceutics16101286.
3
Characterization of Hyaluronic Acid-Coated PLGA Nanoparticles by Surface-Enhanced Raman Spectroscopy.

本文引用的文献

1
Water-soluble hyaluronic acid-hybridized polyaniline nanoparticles for effectively targeted photothermal therapy.用于有效靶向光热治疗的水溶性透明质酸杂交聚苯胺纳米颗粒。
J Mater Chem B. 2015 May 14;3(18):3767-3776. doi: 10.1039/c4tb01738b. Epub 2015 Apr 9.
2
CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.通过使用 HA 修饰的纳米技术靶向递送 CD44 siRNA 以沉默癌症治疗中的 KRAS。
Int J Pharm. 2019 Apr 20;561:114-123. doi: 10.1016/j.ijpharm.2019.02.032. Epub 2019 Feb 26.
3
Hyaluronic Acid Coated Chitosan Nanoparticles Reduced the Immunogenicity of the Formed Protein Corona.
通过表面增强拉曼光谱法对透明质酸包覆的 PLGA 纳米粒子进行表征。
Int J Mol Sci. 2022 Dec 29;24(1):601. doi: 10.3390/ijms24010601.
4
Insights into the internal structures of nanogels using a versatile asymmetric-flow field-flow fractionation method.使用通用的不对称流场流分馏方法深入了解纳米凝胶的内部结构。
Nanoscale Adv. 2020 Aug 18;2(10):4713-4721. doi: 10.1039/d0na00314j. eCollection 2020 Oct 13.
5
Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells.用于硫酸长春碱递送的壳聚糖-透明质酸纳米颗粒:对K-562细胞的表征及内化研究
Pharmaceutics. 2022 Apr 26;14(5):942. doi: 10.3390/pharmaceutics14050942.
6
Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment.载有土木香内酯的壳聚糖/透明质酸纳米颗粒通过使信号转导和转录激活因子3(STAT3)通路失活并限制免疫细胞募集来抑制银屑病。
Asian J Pharm Sci. 2022 Mar;17(2):268-283. doi: 10.1016/j.ajps.2022.02.003. Epub 2022 Feb 27.
7
CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles.靶向CD44的载体:透明质酸分子量在基于透明质酸的纳米颗粒摄取中的作用
Pharmaceuticals (Basel). 2022 Jan 17;15(1):103. doi: 10.3390/ph15010103.
8
Hyaluronic Acid-Based Nanoparticles for Protein Delivery: Systematic Examination of Microfluidic Production Conditions.用于蛋白质递送的基于透明质酸的纳米颗粒:微流体制备条件的系统研究
Pharmaceutics. 2021 Sep 26;13(10):1565. doi: 10.3390/pharmaceutics13101565.
9
Formulation development and evaluation of lidocaine hydrochloride loaded in chitosan-pectin-hyaluronic acid polyelectrolyte complex for dry socket treatment.用于干槽症治疗的壳聚糖-果胶-透明质酸聚电解质复合物负载盐酸利多卡因的制剂研发与评价
Saudi Pharm J. 2021 Sep;29(9):1070-1081. doi: 10.1016/j.jsps.2021.07.007. Epub 2021 Jul 19.
10
Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers.不对称流场流分离技术作为一种多功能技术,用于聚合物纳米载体的表征。
Drug Deliv Transl Res. 2021 Apr;11(2):373-395. doi: 10.1007/s13346-021-00918-5. Epub 2021 Jan 31.
透明质酸包覆壳聚糖纳米粒降低了形成的蛋白冠的免疫原性。
Sci Rep. 2017 Sep 5;7(1):10542. doi: 10.1038/s41598-017-10836-7.
4
Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.壳聚糖/透明质酸纳米颗粒:用于RNA递送的理性设计再探讨
Mol Pharm. 2017 Jul 3;14(7):2422-2436. doi: 10.1021/acs.molpharmaceut.7b00320. Epub 2017 Jun 19.
5
The CD44-Mediated Uptake of Hyaluronic Acid-Based Carriers in Macrophages.CD44 介导的透明质酸载体在巨噬细胞中的摄取。
Adv Healthc Mater. 2017 Feb;6(4). doi: 10.1002/adhm.201601012. Epub 2016 Dec 19.
6
Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.三聚磷酸钠对壳聚糖基纳米颗粒在Raw 264.7巨噬细胞中细胞摄取及RNA干扰效率的影响
J Colloid Interface Sci. 2017 Mar 15;490:520-528. doi: 10.1016/j.jcis.2016.11.088. Epub 2016 Nov 26.
7
Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.离子凝胶法制备壳聚糖纳米颗粒:最新进展综述
Crit Rev Ther Drug Carrier Syst. 2016;33(2):107-58. doi: 10.1615/CritRevTherDrugCarrierSyst.2016014850.
8
Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.用于在异种移植模型中高效治疗结肠癌的阳离子微小RNA递送纳米载体
Gene Ther. 2016 Dec;23(12):829-838. doi: 10.1038/gt.2016.60. Epub 2016 Aug 2.
9
Multifunctional Hyaluronic Acid and Chondroitin Sulfate Nanoparticles: Impact of Glycosaminoglycan Presentation on Receptor Mediated Cellular Uptake and Immune Activation.多功能透明质酸和硫酸软骨素纳米粒子:糖胺聚糖呈现方式对受体介导的细胞摄取和免疫激活的影响。
ACS Appl Mater Interfaces. 2016 Aug 17;8(32):20614-24. doi: 10.1021/acsami.6b06823. Epub 2016 Aug 5.
10
Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.甘露糖化使得透明质酸纳米颗粒能够协同(CD44/C 型凝集素)被树突状细胞摄取,但仅在正确呈现配体的情况下才会发生。
Adv Healthc Mater. 2016 Apr 20;5(8):966-76. doi: 10.1002/adhm.201500941. Epub 2016 Feb 10.